1Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s.Nature,1993,362:801-809.
2Delerive P,De Bosscher K,Besnard S,et al.Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.J Biol Chem,1999,274:32048-32054.
3Torra IP,Gervois P,Staels B.Peroxisome proliferator-activated receptor alpha in metabolic disease,inflammation,atherosclerosis and aging.Curr Opin Lipidol,1999,10:151-159.
4Wang Z,Castresana MR,Newman WH.Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells.Biochem Biophys Res Commun,2001,285:669-674.
5Fruchart JC,Duriez P,Staels B.Molecular mechanism of action of the fibrates.J Soc Biol,1999,193:67-75.
6Xie ML,Gu ZL,Chen KJ,et al.Effect of lipanthyl on mRNA expression of endothelin-1 and nitric-oxide synthase in atherosclerotic vessel wall in rabbits.Acta Pharmacol Sin,2000,21:473-476.
7Chinetti G,Fruchart JC,Staels B.Peroxisome proliferator-activated receptors (PPARs):nuclear receptors with functions in the vascular wall.Z Kardiol,2001,90:125-132.
8Yamada H,Tsushima T,Murakami H,et al.Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells.Int J Exp Diabetes Res,2002,3:131-144.
